Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,435 | -15,040 | -7,638 | -1,570 | -3,827 |
| Depreciation Amortization | 39 | 150 | 106 | 65 | 23 |
| Accounts payable and accrued liabilities | 724 | 388 | 928 | 578 | 302 |
| Other Working Capital | -635 | 2,308 | 1,499 | 526 | 196 |
| Other Operating Activity | -19 | -6,430 | -7,510 | -7,293 | -93 |
| Operating Cash Flow | $-7,326 | $-18,624 | $-12,615 | $-7,694 | $-3,399 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -560 | -551 | -494 | -449 |
| Investing Cash Flow | $-13 | $-560 | $-551 | $-494 | $-449 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 21 | 26 | 5 | N/A | N/A |
| Other Financing Activity | -559 | 93,831 | 21,972 | 22,074 | 0 |
| Financing Cash Flow | $-538 | $93,857 | $21,977 | $22,074 | $N/A |
| Beginning Cash Position | 92,777 | 18,104 | 18,104 | 18,104 | 18,104 |
| End Cash Position | 84,900 | 92,777 | 26,915 | 31,990 | 14,256 |
| Net Cash Flow | $-7,877 | $74,673 | $8,811 | $13,886 | $-3,848 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,326 | -18,624 | -12,615 | -7,694 | -3,399 |
| Capital Expenditure | -13 | -560 | -551 | -494 | -449 |
| Free Cash Flow | -7,339 | -19,184 | -13,166 | -8,188 | -3,848 |